Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report
- PMID: 34804758
- PMCID: PMC8599463
- DOI: 10.7759/cureus.19673
Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report
Abstract
Guillain-Barré syndrome (GBS) is a rare autoimmune disorder that typically develops after a respiratory or gastrointestinal infection. While Campylobacter jejuni is associated with approximately 30% of cases, organisms such as Haemophilus influenzae, Mycoplasma pneumonia, Epstein-Barr virus, cytomegalovirus, Zika virus, influenza virus, and hepatitis A, B, C, and E have demonstrated clinical associations to GBS. In rare instances, Escherichia coli infections have been documented as the underlying cause for GBS. Our patient, a 69-year-old female, was admitted with a two-week history of progressively worsening bilateral lower extremity weakness following diagnosis of an extended-spectrum beta-lactamase E. coli urinary tract infection. She was diagnosed with GBS based on acute flaccid paralysis, areflexia, and a nerve conduction velocity study showing an absent motor response in her lower extremities bilaterally. The patient subsequently underwent intravenous immunoglobulin (IVIG) treatment for five days which resulted in significant improvement in her bilateral lower extremity weakness, a response consistent with the diagnosis of GBS.
Keywords: ascending flaccid paralysis; extended-spectrum beta- lactamase escherichia coli urinary tract infection; guillain-barré syndrome; intravenous immunoglobulin; molecular mimicry; post-infection inflammatory polyradiculoneuropathy.
Copyright © 2021, Fischer et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Recurrent Guillain-Barré Syndrome Following Urinary Tract Infection by Escherichia coli.J Korean Med Sci. 2018 Jan 22;33(4):e29. doi: 10.3346/jkms.2018.33.e29. J Korean Med Sci. 2018. PMID: 29318796 Free PMC article.
-
Guillain-Barré syndrome following falciparum malaria infection: a case report.BMC Neurol. 2025 Jan 25;25(1):37. doi: 10.1186/s12883-025-04049-z. BMC Neurol. 2025. PMID: 39863898 Free PMC article.
-
A Case of Guillain-Barré Syndrome Possibly Associated With COVID-19 Infection.Cureus. 2025 Apr 24;17(4):e82954. doi: 10.7759/cureus.82954. eCollection 2025 Apr. Cureus. 2025. PMID: 40416280 Free PMC article.
-
[Guillain-Barré Syndrome and its association with infectious factors].Neurol Neurochir Pol. 2005 May-Jun;39(3):230-6. Neurol Neurochir Pol. 2005. PMID: 15981163 Review. Polish.
-
Pathogenesis of Guillain-Barré syndrome.J Neuroimmunol. 1999 Dec;100(1-2):74-97. doi: 10.1016/s0165-5728(99)00195-2. J Neuroimmunol. 1999. PMID: 10695718 Review.
References
-
- Rapidly progressive Guillain-Barré syndrome following Escherichia coli infection. Kono Y, Nishitarumizu K, Higashi T, Funakoshi K, Odaka M. Intern Med. 2007;46:589–591. - PubMed
-
- Guillain-Barré Syndrome Fact Sheet. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-She... 2021
-
- The Guillain-Barré syndrome. Ropper AH. N Engl J Med. 1992;326:1130–1136. - PubMed
Publication types
LinkOut - more resources
Full Text Sources